IN2014MN01065A - - Google Patents

Info

Publication number
IN2014MN01065A
IN2014MN01065A IN1065MUN2014A IN2014MN01065A IN 2014MN01065 A IN2014MN01065 A IN 2014MN01065A IN 1065MUN2014 A IN1065MUN2014 A IN 1065MUN2014A IN 2014MN01065 A IN2014MN01065 A IN 2014MN01065A
Authority
IN
India
Prior art keywords
skin
ageing
composition
myricetin
glycoside
Prior art date
Application number
Other languages
English (en)
Inventor
Gail Jenkins
Silvina Beatriz Lotito
Jennifer Elizabeth Pople
Linda Jane Wainwright
Original Assignee
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc filed Critical Unilever Plc
Publication of IN2014MN01065A publication Critical patent/IN2014MN01065A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
IN1065MUN2014 2011-12-06 2012-11-27 IN2014MN01065A (US20040132699A1-20040708-C00002.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11192180 2011-12-06
PCT/EP2012/073697 WO2013083431A1 (en) 2011-12-06 2012-11-27 Skin anti-ageing composition

Publications (1)

Publication Number Publication Date
IN2014MN01065A true IN2014MN01065A (US20040132699A1-20040708-C00002.png) 2015-05-01

Family

ID=47226185

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1065MUN2014 IN2014MN01065A (US20040132699A1-20040708-C00002.png) 2011-12-06 2012-11-27

Country Status (9)

Country Link
US (1) US10406091B2 (US20040132699A1-20040708-C00002.png)
EP (1) EP2788088B1 (US20040132699A1-20040708-C00002.png)
CN (1) CN103957998B (US20040132699A1-20040708-C00002.png)
AU (1) AU2012348700B2 (US20040132699A1-20040708-C00002.png)
BR (1) BR112014013667A2 (US20040132699A1-20040708-C00002.png)
CA (1) CA2857231A1 (US20040132699A1-20040708-C00002.png)
IN (1) IN2014MN01065A (US20040132699A1-20040708-C00002.png)
WO (1) WO2013083431A1 (US20040132699A1-20040708-C00002.png)
ZA (1) ZA201403778B (US20040132699A1-20040708-C00002.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103399151A (zh) * 2013-06-24 2013-11-20 上海交通大学医学院附属瑞金医院 Cxcl8细胞因子检测试剂在制备甲状腺乳头状癌的诊断试剂中的应用
EP3236927B1 (en) * 2014-12-22 2019-11-13 Unilever PLC Hair composition
US20190365784A1 (en) * 2015-12-30 2019-12-05 Raúl Enrique MASSONE Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators
JP6353939B1 (ja) * 2017-02-15 2018-07-04 横関油脂工業株式会社 油状組成物、その製法、油性基剤および皮膚外用剤
CN110769841A (zh) 2017-06-13 2020-02-07 玫琳凯有限公司 化妆品组合物及其用于使皮肤紧致的方法
CN108420778A (zh) * 2018-06-17 2018-08-21 佛山市芊茹化妆品有限公司 一种具有美白功效的组合物及其应用
EP4299051A1 (en) * 2022-06-28 2024-01-03 Cosmax, Inc. Cosmetic composition including garlic extract, black tea extract, and guava extract

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120805A (ja) 1983-11-30 1985-06-28 Akira Kitano 皮膚化粧料
FR2642305A1 (fr) 1989-01-27 1990-08-03 Theramex Laboratoire Nouvelles compositions de dermo-cosmetologie et leur procede d'obtention
US6414037B1 (en) 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
AT407821B (de) 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
CN1195489C (zh) 1999-01-12 2005-04-06 内蒙古宇航人化妆品有限责任公司 沙棘精华素
KR100455470B1 (ko) 1999-05-17 2004-11-06 더 프록터 앤드 갬블 캄파니 피토스테롤 조성물의 국소 적용을 통한 포유류 케라틴조직 상태의 조절 방법
JP2001039849A (ja) 1999-07-27 2001-02-13 Shiseido Co Ltd コラーゲン産生促進剤
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
FR2820975B1 (fr) 2001-02-21 2004-03-12 Oreal Composition pour application topique comprenant au moins un hydroxystilbene et au moins un polyol pour solubiliser l'hydroxystilbene
JP2005509610A (ja) 2001-10-04 2005-04-14 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚の表皮障壁発達の増進
EP1314420A1 (de) * 2001-11-23 2003-05-28 Cognis Iberia, S.L. Anti-Ageing Mittel
EP1327438A1 (de) * 2002-01-12 2003-07-16 Dr. Scheller Cosmetics AG kosmetische Zubereitung und ihre Verwendung
US6579543B1 (en) 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
WO2004034820A2 (en) 2002-10-16 2004-04-29 L'oreal Cosmetic composition for preventing and/or correcting the functional disorders of the pilo-sebaceous unit of mammals
WO2004058213A1 (en) * 2002-12-27 2004-07-15 Hankook Pharm. Co., Inc. Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement
KR100600249B1 (ko) 2002-12-27 2007-04-12 주식회사한국신약 항산화 및 노화 억제 활성을 가지는 박태기나무 추출물 및이를 함유하는 항산화, 피부 노화 억제 및 주름 개선용화장료 조성물
GB0311816D0 (en) 2003-05-22 2003-06-25 Unilever Plc Skin treatments
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung
US7320797B2 (en) 2003-08-29 2008-01-22 Bioderm Research Antiaging cosmetic delivery systems
US20050186171A1 (en) 2004-02-23 2005-08-25 Winick Bernyce A. Skin cream
US7455860B2 (en) 2004-08-11 2008-11-25 Laila Nutraceuticals Dietary supplement formulation for controlling inflammation and cancer
US20060078530A1 (en) 2004-10-12 2006-04-13 Liu Kay M Using high-density grapes to rejuvenate human skin
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20060229265A1 (en) 2005-03-30 2006-10-12 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
CA2546464A1 (en) 2005-05-04 2006-11-04 Richard Wachsberg Sequential application of oral and topical formulations for treating wrinkles and other damage to skin
US20070048246A1 (en) 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
WO2007029982A1 (en) * 2005-09-08 2007-03-15 Amorepacific Corporation Composition of skin external application for anti-aging
US20080262081A1 (en) 2005-10-14 2008-10-23 Daniel Raederstorff Novel Use of Nutraceutical Compositions Comprising Resveratrol
WO2007073765A1 (en) 2005-12-28 2007-07-05 Marfarma Holding S.P.A. Methylselenol zinc salt and compositions containing it
JP4954564B2 (ja) * 2006-02-10 2012-06-20 一丸ファルコス株式会社 メイラード反応生成物であるタンパク質−還元糖架橋物質を分解する製剤
CA2641950A1 (en) 2006-02-10 2007-08-23 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
US20070225360A1 (en) 2006-03-22 2007-09-27 L'oreal Anti-aging composition containing phloretin
FR2898808B1 (fr) 2006-03-27 2008-05-02 Biotechmarine Soc Par Actions "principe actif cosmetique compose de ferrulate d'arginine et d'un extrait de microalgue et ses utilisations".
EA200802090A1 (ru) 2006-03-31 2010-04-30 ДСМ АйПи АССЕТС Б.В. Новое применение соединений и комбинаций соединений для улучшения внешнего вида
WO2007146023A1 (en) 2006-06-06 2007-12-21 Massachusetts Institute Of Technology Cholesterol-regulating complex of sirt1 and lxr and methods of use
ITLO20060004A1 (it) 2006-08-08 2008-02-09 River Pharma Srl "lapille" e una nuova invenzione avente per oggetto una nuova combinazione chimica stabile per uso cosmetico e farmaceutico contenente come ingredienti attivi l'acido alfa-lipoico ed il dimetilsulfossido, in grado di migliorare l'assorbimento, la bio
US8435547B2 (en) 2006-08-30 2013-05-07 John P. Blass Cream for stimulating mitochondrial activity in the skin
US20080070883A1 (en) 2006-09-19 2008-03-20 Wyeth Use of LXR modulators for the prevention and treatment of skin aging
KR100883757B1 (ko) * 2007-03-12 2009-02-12 성균관대학교산학협력단 신경전달물질 배출을 조절하기 위한 폴리페놀 화합물
JP2008239576A (ja) 2007-03-28 2008-10-09 Koei Kogyo Kk ブドウの芽及び蔓から抽出したレスベラトロール類を含有する組成物
US20100210692A1 (en) 2007-03-28 2010-08-19 Farmer Stephen R Methods of treatment using sirt modulators and compositions containing sirt1 modulators
US7794758B2 (en) 2007-04-05 2010-09-14 Pmc Formulas, Inc. Compounds and methods for promoting cellular health and treatment of cancer
US20080254135A1 (en) 2007-04-10 2008-10-16 Marvin Heuer Resveratrol-containing compositions for general health and vitality
US20100099640A1 (en) 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
EP1992322A1 (en) 2007-05-11 2008-11-19 Dr. Scheller Cosmetics AG Composition for percutaneous application
EP2005941A3 (de) 2007-06-01 2009-04-01 Henkel AG & Co. KGaA Zellverjüngende Zusammensetzungen
WO2009003798A1 (en) 2007-07-05 2009-01-08 Unilever N.V. Food composition comprising trans-resveratrol and its use to control blood pressure
US20090028895A1 (en) 2007-07-27 2009-01-29 Smith Walter P Methods and compositions for reducing facial lines and wrinkles
US20090047309A1 (en) 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
JP5281645B2 (ja) 2007-09-08 2013-09-04 イーエルシー マネージメント エルエルシー フェルラ酸レスベラトロール化合物、それらの化合物を含有する組成物およびそれらの使用方法。
FR2923717B1 (fr) 2007-11-15 2015-01-16 Caudalie Compositions de derives polyphenoliques stilbeniques et leurs applications pour lutter contre les pathologies et le veillissement des organismes vivants
US8535738B2 (en) 2007-12-20 2013-09-17 Elc Management, Llc Methods and compositions for treating skin
EP2249806A2 (en) 2008-01-08 2010-11-17 Sirtris Pharmaceuticals, Inc. Resveratrol formulations
US20090324705A1 (en) 2008-02-13 2009-12-31 Nina Vikhrieva Phytonutrient compositions for topical use
US8029830B2 (en) 2008-04-18 2011-10-04 Nuvocare Health Services Inc. Composition and method for promoting internal health and external appearance
PE20091928A1 (es) 2008-05-29 2009-12-31 Bristol Myers Squibb Co Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
ES2316312B1 (es) 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
EP2313074A4 (en) 2008-06-30 2015-04-15 Elc Man Llc TOPICAL COMPOSITIONS CONTAINING ISONICOTINAMIDE
GB0811992D0 (en) 2008-07-01 2008-08-06 Mithen Richard Treatment
US20110269817A1 (en) 2008-07-24 2011-11-03 The Regents Of The University Of California Compositions and methods related to sirt1 function
DE102008047362A1 (de) 2008-09-15 2010-04-15 Henkel Ag & Co. Kgaa Zusammensetzung zur Hautaufhellung
US9566256B2 (en) 2008-09-22 2017-02-14 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
WO2010039529A2 (en) 2008-09-23 2010-04-08 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treament of inflammatory disease
ES2349966B1 (es) 2008-10-30 2011-11-18 Ignacio Umbert Millet Formulaciones topicas para el tratamiento de verrugas.
FR2938765B1 (fr) 2008-11-26 2010-12-31 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur des proteines sirt
WO2010090830A1 (en) 2009-01-20 2010-08-12 Isis Pharmaceuticals, Inc. Modulation of sirt1 expression
US20100215781A1 (en) 2009-02-25 2010-08-26 Joar Opheim Therapeutic composition comprising omega-3 polyunsaturated fatty acid or derivative thereof, resveratrol and green tea
JP2010202617A (ja) 2009-03-05 2010-09-16 Kose Corp 一重項酸素消去剤およびこれを含有する皮膚外用剤ならびに化粧料
US20100233128A1 (en) 2009-03-13 2010-09-16 Mci Media Capital Inc. Natural Skin Products Containing Dairy and Processes
FR2949044B1 (fr) 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable
ITMI20091940A1 (it) 2009-11-05 2011-05-06 Functional Point S R L Composizione comprendente resveratrolo e almeno un polifenolo del vino rosso e suoi usi.

Also Published As

Publication number Publication date
EP2788088A1 (en) 2014-10-15
BR112014013667A2 (pt) 2017-06-13
EP2788088B1 (en) 2019-06-19
US10406091B2 (en) 2019-09-10
AU2012348700A1 (en) 2014-06-12
AU2012348700B2 (en) 2015-08-27
WO2013083431A1 (en) 2013-06-13
US20140295010A1 (en) 2014-10-02
CA2857231A1 (en) 2013-06-13
ZA201403778B (en) 2015-11-25
CN103957998A (zh) 2014-07-30
CN103957998B (zh) 2018-06-12

Similar Documents

Publication Publication Date Title
IN2014MN01065A (US20040132699A1-20040708-C00002.png)
EP3035908A4 (en) Topical skin compositions for treating wrinkles
SG11201604697TA (en) Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
EP2528455A4 (en) METHODS OF TREATING GLYCOSIDE MIXTURES TO OBTAIN ONE OR MORE OF THESE GLYCOSIDES IN PURE FORM
IN2015DN03898A (US20040132699A1-20040708-C00002.png)
MX349544B (es) Extractos de maesa japonica y métodos de uso.
HK1185230A1 (en) Composition comprising imidazole peptide and quercetin glycoside
MX2017007868A (es) Composiciones para proporcionar una proteccion de filtro solar mejorada.
PH12015502405B1 (en) Methods and compositions for wound healing
HK1217453A1 (zh) 用於改善疤痕組織的外觀和形成的方法及組合物
WO2012092350A3 (en) Topical uses szeto-schiller peptides
GB2541318A (en) Use of undaria extract to reduce signs of skin aging
MX2016013135A (es) Composiciones y metodos para reducir el estres oxidativo.
EP3366694A4 (en) NOVEL PEPTIDE AND COSMETIC COMPOSITION FOR PREVENTING AGING OF SKIN OR FORMATION OF WRINKLES CONTAINING IT
GB201901812D0 (en) Improvements in or relating to fire-rated door sets
GB2541315A (en) Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
BR112015022265B8 (pt) Composições pigmentadas para tratamento da pele
BR112015022275B8 (pt) Composições pigmentadas para tratamento da pele
GB201217419D0 (en) Improvements in or relating to oromucosal apomorphine compositions
WO2012173383A3 (ko) 크립토탄시논을 유효성분으로 함유하는 피부 외용제 조성물
MX366268B (es) Composicion topica que incluye una combinacion de extractos para reducir los signos de envejecimiento de la piel.
GB2541317A (en) Methods of reducing signs of skin aging
GB2541576A (en) Methods of reducing signs of skin aging using a combination of extracts
MX2016013544A (es) Uso del extracto de bidens para reducir los signos de envejecimiento de la piel.
GB201902073D0 (en) Improvements in or relating to hardware